DIFFERENCES IN OUTCOMES BETWEEN WOMEN AND MEN ASSOCIATED WITH PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - A REGIONAL PROSPECTIVE-STUDYOF 13061 PROCEDURES

Citation
Dj. Malenka et al., DIFFERENCES IN OUTCOMES BETWEEN WOMEN AND MEN ASSOCIATED WITH PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - A REGIONAL PROSPECTIVE-STUDYOF 13061 PROCEDURES, Circulation, 94(9), 1996, pp. 99-104
Citations number
31
Categorie Soggetti
Cardiac & Cardiovascular System",Hematology
Journal title
ISSN journal
00097322
Volume
94
Issue
9
Year of publication
1996
Supplement
S
Pages
99 - 104
Database
ISI
SICI code
0009-7322(1996)94:9<99:DIOBWA>2.0.ZU;2-B
Abstract
Background A prospective study of patients undergoing percutaneous tra nsluminal coronary angioplasty was conducted to examine differences in mortality and nonfatal outcomes by sex. Data were collected on 12 232 patients representing 13 061 trips to the catheterization laboratory for percutaneous transluminal coronary angioplasty (PTCA) of 17 096 le sions between 1989 and 1993. Differences in patient characteristics, c omorbidities, severity of illness, and treatments were examined and cr ude and adjusted odds ratios (ORs) for women versus men reported. Meth ods and Results Rates of success, fatal and nonfatal outcomes, ORs, an d 95% CIs were calculated. Clinical success for women (88.8%) and men (87.9%) was good and comparable. Mortality rates for women (1.64%) and men (0.7%) differed, with an OR (women versus men) of 2.34 (95% CI, 1 .64, 3.35). Nonfatal adverse outcomes rates (coronary artery bypass gr afting and myocardial infarction) for women (5.29%) and for men (4.29% ) were of borderline significance, with an OR of 1.19 (95% CI, 1.00, 1 .41). Women were older, were more likely to be hypertensive and diabet ic, and had more urgent and emergent procedures. For mortality, the ad justed OR (women versus men) was 1.64 (95% CI, 1.09, 2.47), and for no nfatal adverse outcomes, the OR was 1.14 (95% CI, 0.95, 1.36). Conclus ions Although the success rate of PTCA for men and women is comparable , women are at higher risk for adverse outcomes. For nonfatal events, the excess risk is attributable to differences in case mix. For death, the risk remains elevated even after adjusting for case mix.